Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]

Wenli Dang,Bin Xing,Xintao Jia,Ying Zhang,Bei Jia,Changxiang Yu,Jiachen He,Ziwei Li,Huihui Li,Zhidong Liu

DOI: https://doi.org/10.2147/ijn.s431592

IF: 7.033

2023-08-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S413680.].

pharmacology & pharmacy,nanoscience & nanotechnology

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Wancun Zhang,Lili Xia,Xiangyu Ren,Mengyuan Cui,Tianguang Liu,Chen Ling,Yanqi Xu,Dawei Deng,Xianwei Zhang,Yueqing Gu,Peng Wang

DOI: https://doi.org/10.1039/d4bm90077d

2024-10-25

Biomaterials Science

Abstract:Correction for 'The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer' by Wancun Zhang et al. , Biomater. Sci. , 2020, 8 , 5941–5954, https://doi.org/10.1039/D0BM01035A.

materials science, biomaterials
Corrigendum: Docetaxel-loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer

Xing Feng,Xiaoling Xiong,Shenglin Ma

DOI: https://doi.org/10.3389/fphar.2022.964540

IF: 5.6

2022-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.832725.].
Correction: Ce6-Conjugated and Polydopamine-Coated Gold Nanostars with Enhanced Photoacoustic Imaging and Photothermal/photodynamic Therapy to Inhibit Lung Metastasis of Breast Cancer.

Ziwei Li,Fan Yang,Di Wu,Yanhong Liu,Yang Gao,Haichen Lian,Hongxin Zhang,Zhibin Yin,Aiguo Wu,Leyong Zeng

DOI: https://doi.org/10.1039/d4nr90194k

IF: 6.7

2024-01-01

Nanoscale

Abstract:Correction for 'Ce6-Conjugated and polydopamine-coated gold nanostars with enhanced photoacoustic imaging and photothermal/photodynamic therapy to inhibit lung metastasis of breast cancer' by Ziwei Li et al., Nanoscale, 2020, 12, 22173-22184, https://doi.org/10.1039/D0NR05386D.
Correction To: Targeted Therapy for Cisplatin‐resistant Lung Cancer Via Aptamer‐guided Nano‐zinc Carriers Containing USP14 Sirna

Xinmin Zhao,Xianghua Wu,Huijie Wang,Songtao Lai,Jialei Wang

DOI: https://doi.org/10.1002/mco2.237

2023-01-01

MedComm

Abstract:[This corrects the article DOI: 10.1002/mco2.237.].
Correction: MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer

Jie Liu,Chang-Qing Yang,Qiang Chen,Tong-Yao Yu,Shi-Long Zhang,Wei-Hong Guo,Li-Heng Luo,Gang Zhao,Da-Chuan Yin,Chen-Yan Zhang

DOI: https://doi.org/10.1039/d4bm90014f

2024-02-17

Biomaterials Science

Abstract:Correction for 'MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer' by Jie Liu et al. , Biomater. Sci. , 2022, 10 , 4596–4611, https://doi.org/10.1039/D2BM00543C.

materials science, biomaterials
Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Qi Chang Zheng,Shuai Jiang,Yu Zhe Wu,Dan Shang,Yong Zhang,Shao Bo Hu,Xiang Cheng,Chen Zhang,Ping Sun,Yang Gao,Zi Fang Song,Min Li

DOI: https://doi.org/10.3389/fbioe.2021.656268

IF: 5.7

2021-02-11

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00512.].

multidisciplinary sciences
Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.

Yali Jia,Zonghai Sheng,Dehong Hu,Fei Yan,Mingting Zhu,Guanhui Gao,Pan Wang,Xin Liu,Xiaobing Wang,Hairong Zheng

DOI: https://doi.org/10.1039/d1bm90047a

2021-01-01

Biomaterials Science

Abstract:Correction for 'Highly penetrative liposome nanomedicine generated by a biomimetic strategy for enhanced cancer chemotherapy' by Yali Jia et al., Biomater. Sci., 2018, 6, 1546-1555, DOI: 10.1039/C8BM00256H.
Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Fuqiang Xing,Nana Ai,Shigao Huang,Cheng Jiang,Muhammad Jameel Mughal,Wei Ge,Guanyu Wang,Chu-Xia Deng

DOI: https://doi.org/10.3389/fbioe.2022.1039177

IF: 5.7

2022-09-26

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2022.839078.].

multidisciplinary sciences
Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Qing Shi,Xingxing Zhang,Minmin Wu,Yuhan Xia,Yating Pan,Jialu Weng,Na Li,Xingjie Zan,Jinglin Xia

DOI: https://doi.org/10.1016/j.mtbio.2023.100916

2023-12-26

Abstract:[This corrects the article DOI: 10.1016/j.mtbio.2023.100873.].
Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

DOI: https://doi.org/10.2147/IJN.S500182

2024-10-14

Abstract:[This corrects the article DOI: 10.2147/IJN.S448556.].
Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum

Jianbin Xu,Guolin Zhang,Xin Luo,Di Wang,Wei Zhou,Yan Zhang,Wei Zhang,Jiaxin Chen,Qing Meng,Engeng Chen,Heng Chen,Zhangfa Song

DOI: https://doi.org/10.7150/thno.76869

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.52076.].

medicine, research & experimental
Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Hongye He,Feng Li,Rui Tang,Nianhong Wu,Ying Zhou,Yuting Cao,Can Wang,Li Wan,Yang Zhou,Hua Zhuang,Pan Li

DOI: https://doi.org/10.34133/bmr.0088

2024-10-07

Abstract:[This corrects the article DOI: 10.34133/bmr.0064.].
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Yi Qian,Meimei Zhao,Qinghua Han,Jingkang Wang,Lixi Liao,Heng Yang,Dan Liu,Pengfei Tu,Hong Liang,Kewu Zeng

DOI: https://doi.org/10.1016/j.apsb.2024.02.013

IF: 14.903

2024-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.01.011.].
Corrigendum: Biodegradable hollowed mesoporous SeO2 nanoplatform loaded with indocyanine green for simultaneous NIR II fluorescence imaging and synergistic breast carcinoma therapy

Tingwei Peng,Qing Liu,Hui Song,Conghui Zhang,Xue Wang,Ping Ru,Tianzhao Xu,Xinghui Liu

DOI: https://doi.org/10.3389/fbioe.2023.1201751

IF: 5.7

2023-04-21

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2023.1151148.].

multidisciplinary sciences
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology
Preparation of AS1411 Aptamer Modified Mn-MoS2 QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma [Corrigendum]

Shaohui Zheng,Min Zhang,Hongyan Bai,Meijuan He,Lina Dong,Lulu Cai,Mingming Zhao,Qi Wang,Kai Xu,Jingjing Li

DOI: https://doi.org/10.2147/ijn.s405918

IF: 7.033

2023-01-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S215883.].

pharmacology & pharmacy,nanoscience & nanotechnology

Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Correction: The improved targeting of an aspirin prodrug albumin-based nanosystem for visualizing and inhibiting lung metastasis of breast cancer

Corrigendum: Docetaxel-loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer

Correction: Ce6-Conjugated and Polydopamine-Coated Gold Nanostars with Enhanced Photoacoustic Imaging and Photothermal/photodynamic Therapy to Inhibit Lung Metastasis of Breast Cancer.

Correction To: Targeted Therapy for Cisplatin‐resistant Lung Cancer Via Aptamer‐guided Nano‐zinc Carriers Containing USP14 Sirna

Correction: MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Correction: Highly Penetrative Liposome Nanomedicine Generated by a Biomimetic Strategy for Enhanced Cancer Chemotherapy.

Corrigendum: An in vivo fluorescence resonance energy transfer-based imaging platform for targeted drug discovery and cancer therapy

Corrigendum to "Emulsifying Lipiodol with pH-Sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis" Mater. Today Bio, 23, 2023, 100873, ISSN 2590-0064

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts: Erratum

Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Author Correction to ‘pharmacologically Targeting Molecular Motor Promotes Mitochondrial Fission for Anti-Cancer’ [acta Pharm Sin B 11 (2021) 1853–1866]

Corrigendum: Biodegradable hollowed mesoporous SeO2 nanoplatform loaded with indocyanine green for simultaneous NIR II fluorescence imaging and synergistic breast carcinoma therapy

Corrigendum: Lipid metabolism and tumor immunotherapy

Preparation of AS1411 Aptamer Modified Mn-MoS2 QDs for Targeted MR Imaging and Fluorescence Labelling of Renal Cell Carcinoma [Corrigendum]